✦ LIBER ✦

Delayed hypersensitivity to one low-molecular-weight heparin with tolerance of other low-molecular-weight heparins

✍ Scribed by A.J BIRCHER; P.H ITIN; D.A TSAKIRIS; C. SURBER

Book ID: 108666816
Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 227 KB
Volume: 132
Category: Article
ISSN: 0007-0963
DOI: 10.1111/j.1365-2133.1995.tb08684.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Delayed-type hypersensitivity to low mol

Delayed-type hypersensitivity to low molecular weight heparins and heparinoids: cross-reactivity does not depend on molecular weight

✍ R.H. Grims; W. Weger; H. Reiter; E. Arbab; B. Kränke; W. Aberer 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB

Delayed hypersensitivity at the injectio

Delayed hypersensitivity at the injection sites of a low-molecular-weight heparin

✍ A. Moreau; A. Dompmartin; P. Esnault; M. Michel; D. Leroy 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 554 KB

Tolerance of intravenous low-molecular-w

Tolerance of intravenous low-molecular-weight heparin after eczematous reaction to subcutaneous heparin

✍ P. Koch; F. A. Bahmer; H. Schäfer 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB

Delayed-type hypersensitivity to low mol

Delayed-type hypersensitivity to low molecular weight heparins and heparinoids: cross-reactivity does not depend on molecular weight. Commentary

✍ A. Gómez-Outes; C. Gómez de la Bárcena; J. Martínez-González 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Recommendations on biosimilar low-molecu

Recommendations on biosimilar low-molecular-weight heparins

✍ J. HARENBERG; A. KAKKAR; D. BERGQVIST; T. BARROWCLIFFE; B. CASU; J. FAREED; P. M 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

Nasal administration of low molecular we

Nasal administration of low molecular weight heparin

✍ John Arnold; Fakhrul Ahsan; Elias Meezan; Dennis J. Pillion 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

The main objective of this study was to determine if the systemic absorption of therapeutic amounts of heparin was possible following nasal administration. Sprague-Dawley rats received nosedrops containing a low molecular weight heparin (LMWH) or unfractionated heparin (UFH) formulated with or witho